AZD1332 | AZD1332 : ATP competitive inhibitor of NTRK1 and NTRK2
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (2 reviews)
Control Compounds

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
NTRK1
  • IC 50:2 nM
  • EC 50:1.2 nM
NTRK2
  • IC 50:8 nM
  • EC 50:1.2 nM
Inhibitor
50-100 nM

Selectivity

In Vitro Selectivity Assessment

Potency: IC50 - FGFR1 24 nM

Selectivity Assessment Description:
In vitro selectivity profiling across a broad panel of 177 kinases (Millipore's Kinase Profiler) sho ...
In Cell Selectivity Assessment

Potency: EC50 - FGFR1 41 nM

Selectivity Assessment Description:
Cell selectivity (EC50): 4077 nM (IGF1R), >1000 nM (Aurora), >3000 (CSF1R), >5000 nM (InsR, Akt, p70 ...

Potency
Cellular
In Vitro

NTRK1

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/jm800343j

NTRK2

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/jm800343j

In Vivo Validations

Rat, Dog
Dose: 3 mg/Kg IV, 10 mg/Kg PO, Reviewer suggest 50-100 mg/Kg
Route of delivery: Intravenous, Oral
Plasma half life: 1.4 (R), 7.5 (D) h
Systemic clearance: 17 (R), 9 (D) mL/min/kg

DOI Reference: 10.1021/jm800343j

Chemical Information

Molecular Formula C17H19ClFN7O
SMILEs CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)ncc2Cl)[nH]n1
InChI InChI=1S/C17H19ClFN7O/c1-9(2)27-15-6-14(25-26-15)23-16-12(18)8-21-17(24-16)22-10(3)13-5-4-11(19)7-20-13/h4-10H,1-3H3,(H3,21,22,23,24,25,26)/t10-/m0/s1
Molecular weight 391.13 Da
AlogP 4.091100000000002
HBond acceptors 8
HBond donors 3
Atoms 46

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


(on 10 Apr 2021)
Cellular Use Rating
In Model Organisms
The two cited publications provide a range of biochemical, cell-based, and in vivo assays demonstrating NTRK1/2/3 inhibition. Biochemical and cellular potency is very high for this small kinase family,...
(on 19 Apr 2021)
Cellular Use Rating
In Model Organisms
AZD1332 is an excellent selective Tropomyosin-related kinase A inhibitor, with proven in vitro and in vivo efficacy.
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria